|
1
|
Brawn J, Morotti M, Zondervan KT, Becker
CM and Vincent K: Central changes associated with chronic pelvic
pain and endometriosis. Hum Reprod Update. 20:737–747. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ulukus M, Cakmak H and Arici A: The role
of endometrium in endometriosis. J Soc Gynecol Investig.
13:467–476. 2006.PubMed/NCBI
|
|
3
|
de Ziegler D, Borghese B and Chapron C:
Endometriosis and infertility: pathophysiology and management.
Lancet. 376:730–738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tseng JF, Ryan IP, Milam TD, Murai JT,
Schriock ED, Landers DV and Taylor RN: Interleukin-6 secretion in
vitro is up-regulated in ectopic and eutopic endometrial stromal
cells from women with endometriosis. J Clin Endocrinol Metab.
81:1118–1122. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noble LS, Simpson ER, Johns A and Bulun
SE: Aromatase expression in endometriosis. J Clin Endocrinol Metab.
81:174–179. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nishida M, Nasu K, Ueda T, Fukuda J, Takai
N and Miyakawa I: Endometriotic cells are resistant to
interferon-gamma-induced cell growth inhibition and apoptosis: a
possible mechanism involved in the pathogenesis of endometriosis.
Mol Hum Reprod. 11:29–34. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zeitoun K, Takayama K, Sasano H, Suzuki T,
Moghrabi N, Andersson S, Johns A, et al: Deficient
17beta-hydroxysteroid dehydrogenase type 2 expression in
endometriosis: failure to metabolize 17beta-estradiol. J Clin
Endocrinol Metab. 83:4474–4480. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nishida M, Nasu K, Fukuda J, Kawano Y,
Narahara H and Miyakawa I: Down-regulation of interleukin-1
receptor type 1 expression causes the dysregulated expression of
CXC chemokines in endometriotic stromal cells: a possible mechanism
for the altered immunological functions in endometriosis. J Clin
Endocrinol Metab. 89:5094–5100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taylor HS, Bagot C, Kardana A, Olive D and
Arici A: HOX gene expression is altered in the endometrium of women
with endometriosis. Hum Reprod. 14:1328–1331. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Healy DL, Rogers PA, Hii L and Wingfield
M: Angiogenesis: a new theory for endometriosis. Hum Reprod Update.
4:736–740. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferrara N: Vascular endothelial growth
factor: basic science and clinical progress. Endocr Rev.
25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferrara N, Houck K, Jakeman L and Leung
DW: Molecular and biological properties of the vascular endothelial
growth factor family of proteins. Endocr Rev. 13:18–32. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sunderkotter C, Steinbrink K, Goebeler M,
Bhardwaj R and Sorg C: Macrophages and angiogenesis. J Leukoc Biol.
55:410–422. 1994.PubMed/NCBI
|
|
14
|
Verheul HM, Hoekman K, Luykx-de Bakker S,
Eekman CA, Folman CC, Broxterman HJ and Pinedo HM: Platelet:
transporter of vascular endothelial growth factor. Clin Cancer Res.
3:2187–2190. 1997.PubMed/NCBI
|
|
15
|
Frank S, Hubner G, Breier G, Longaker MT,
Greenhalgh DG and Werner S: Regulation of vascular endothelial
growth factor expression in cultured keratinocytes. Implications
for normal and impaired wound healing. J Biol Chem.
270:12607–12613. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iijima K, Yoshikawa N, Connolly DT and
Nakamura H: Human mesangial cells and peripheral blood mononuclear
cells produce vascular permeability factor. Kidney Int. 44:959–966.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Groothuis PG, Nap AW, Winterhager E and
Grümmer R: Vascular development in endometriosis. Angiogenesis.
8:147–156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
May K and Becker CM: Endometriosis and
angiogenesis. Minerva Ginecol. 60:245–254. 2008.PubMed/NCBI
|
|
19
|
Taylor RN, Lebovic DI and Mueller MD:
Angiogenic factors in endometriosis. Ann NY Acad Sci. 955:89–100.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McLaren J: Vascular endothelial growth
factor and endometriotic angiogenesis. Hum Reprod Update. 6:45–55.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laschke MW, Schwender C, Vollmar B and
Menger MD: Genistein does not affect vascularization and blood
perfusion of endometriotic lesions and ovarian follicles in dorsal
skinfold chambers of Syrian golden hamsters. Reprod Sci.
17:568–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Laschke MW and Menger MD: In vitro and in
vivo approaches to study angiogenesis in the pathophysiology and
therapy of endometriosis. Hum Reprod Update. 13:331–342. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Emamifar B, Salehi Z, Mehrafza M and
Mashayekhi F: The vascular endothelial growth factor (VEGF)
polymorphisms and the risk of endometriosis in northern Iran.
Gynecol Endocrinol. 28:447–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toktam M, Kioomars SN, Kourosh K, Adel S,
Behrokh MM, Mohhamad Mehdi A and Hamid Reza KK: Association of
vascular endothelial growth factor (VEGF) +405 g>c polymorphism
with endometriosis in an Iranian population. J Reprod Infertil.
11:33–37. 2010.PubMed/NCBI
|
|
25
|
Kim JG, Kim JY, Jee BC, Suh CS, Kim SH and
Choi YM: Association between endometriosis and polymorphisms in
endostatin and vascular endothelial growth factor and their serum
levels in Korean women. Fertil Steril. 89:243–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Attar R, Agachan B, Kuran SB, Toptas B,
Eraltan IY, Attar E and Isbir T: Genetic variants of vascular
endothelial growth factor and risk for the development of
endometriosis. In Vivo. 24:297–301. 2010.PubMed/NCBI
|
|
27
|
Altinkaya SO, Ugur M, Ceylaner G, Ozat M,
Gungor T and Ceylaner S: Vascular endothelial growth factor +405
C/G polymorphism is highly associated with an increased risk of
endometriosis in Turkish women. Arch Gynecol Obstet. 283:267–272.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vanaja MC, Rozati R, Nassaruddin K and
Vishnupriya S: Association of VEGF +405G>C polymorphism with
endometriosis. Front Biosci (Elite Ed). 5:748–754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SH, Choi YM, Choung SH, Jun JK, Kim JG
and Moon SY: Vascular endothelial growth factor gene +405 C/G
polymorphism is associated with susceptibility to advanced stage
endometriosis. Hum Reprod. 20:2904–2908. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
No authors listed, . Revised American
Society for Reproductive Medicine classification of endometriosis:
1996. Fertil Steril. 67:817–821. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Szczepańska M, Wirstlein P, Skrzypczak J
and Jagodziński PP: Polymorphic variants of CYP17 and CYP19A and
risk of infertility in endometriosis. Acta Obstet Gynecol Scand.
92:1188–1193. 2013.PubMed/NCBI
|
|
32
|
Szubert M, Suzin J, Duechler M, Szuławska
A, Czyż M and Kowalczyk-Amico K: Evaluation of selected angiogenic
and inflammatory markers in endometriosis before and after danazol
treatment. Reprod Fertil Dev. 26:414–420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pupo-Nogueira A, de Oliveira RM, Petta CA,
Podgaec S, Dias JA Jr and Abrao MS: Vascular endothelial growth
factor concentrations in the serum and peritoneal fluid of women
with endometriosis. Int J Gynaecol Obstet. 99:33–37. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cho S, Choi YS, Jeon YE, Im KJ, Choi YM,
Yim SY, Kim H, Seo SK and Lee BS: Expression of vascular
endothelial growth factor (VEGF) and its soluble receptor-1 in
endometriosis. Microvasc Res. 83:237–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Braza-Boïls A, Gilabert-Estellés J, Ramón
LA, Gilabert J, Marí-Alexandre J, Chirivella M, España F and
Estellés A: Peritoneal fluid reduces angiogenesis-related micro RNA
expression in cell cultures of endometrial and endometriotic
tissues from women with endometriosis. PLoS One. 8:e623702013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee TC and Ho HC: Effects of prostaglandin
E2 and vascular endothelial growth factor on sperm might lead to
endometriosis-associated infertility. Fertil Steril. 95:360–362.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Machado DE, Berardo PT, Palmero CY and
Nasciutti LE: Higher expression of vascular endothelial growth
factor (VEGF) and its receptor VEGFR-2 (Flk-1) and
metalloproteinase-9 (MMP-9) in a rat model of peritoneal
endometriosis is similar to cancer diseases. J Exp Clin Cancer Res.
29:42010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu H, Zhang T, Man GC, May KE, et al:
Vascular endothelial growth factor C is increased in endometrium
and promotes endothelial functions, vascular permeability and
angiogenesis and growth of endometriosis. Angiogenesis. 16:541–551.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ceyhan ST, Onguru O, Fidan U, Ide T, Yaman
H, Kilic S and Baser I: Comparison of aromatase inhibitor
(letrozole) and immunomodulators (infliximab and etanercept) on the
regression of endometriotic implants in a rat model. Eur J Obstet
Gynecol Reprod Biol. 154:100–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sevket O, Sevket A, Buyukpinarbasili N,
Molla T, Kilic G, Ates S and Dansuk R: The effects of ranibizumab
on surgically induced endometriosis in a rat model: a preliminary
study. Reprod Sci. 20:1224–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ergenoğlu AM, Yeniel AÖ, Erbaş O, Aktuğ H,
Yildirim N, Ulukuş M and Taskiran D: Regression of endometrial
implants by resveratrol in an experimentally induced endometriosis
model in rats. Reprod Sci. 20:1230–1236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen
HS, Chang Y, Chuang HY, Lee JN, Hsu YL and Tsai EM: miRNA-199a-5p
regulates VEGFA in endometrial mesenchymal stem cells and
contributes to the pathogenesis of endometriosis. J Pathol.
232:330–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gentilini D, Somigliana E, Vigano P,
Vignali M, Busacca M and Di Blasio AM: The vascular endothelial
growth factor +405G>C polymorphism in endometriosis. Hum Reprod.
23:211–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bhanoori M, Arvind Babu K, Pavankumar
Reddy NG, Lakshmi Rao K, Zondervan K, Deenadayal M, Kennedy S and
Shivaji S: The vascular endothelial growth factor (VEGF) +405G>C
5′-untranslated region polymorphism and increased risk of
endometriosis in South Indian women: a case control study. Hum
Reprod. 20:1844–1849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cosín R, Gilabert-Estellés J, Ramón LA,
España F, Gilabert J, Romeu A and Estellés A: Vascular endothelial
growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and
endometriosis: their influence on vascular endothelial growth
factor expression. Fertil Steril. 92:1214–1220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ikuhashi Y, Yoshida S, Kennedy S,
Zondervan K, Takemura N, Deguchi M, Ohara N and Maruo T: Vascular
endothelial growth factor +936 C/T polymorphism is associated with
an increased risk of endometriosis in a Japanese population. Acta
Obstet Gynecol Scand. 86:1352–1358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li YZ, Wang LJ, Li X, Li SL, Wang JL, Wu
ZH, Gong L and Zhang XD: Vascular endothelial growth factor gene
polymorphisms contribute to the risk of endometriosis: an updated
systematic review and meta-analysis of 14 case-control studies.
Genet Mol Res. 12:1035–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xu S, Wu W, Sun H, et al: Association of
the vascular endothelial growth factor gene polymorphisms (-460C/T,
+405G/C and +936T/C) with endometriosis: a meta-analysis. Ann Hum
Genet. 76:464–471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liang S, Huang Y and Fan Y: Vascular
endothelial growth factor gene polymorphisms and endometriosis
risk: a meta-analysis. Arch Gynecol Obstet. 286:139–146. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lamp M, Saare M, Laisk T, Karro H,
Kadastik U, Metspalu A, Peters M and Salumets A: Genetic variations
in vascular endothelial growth factor but not in angiotensin
I-converting enzyme genes are associated with endometriosis in
Estonian women. Eur J Obstet Gynecol Reprod Biol. 153:85–89. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu Q, Li Y, Zhao J, Sun DL, Duan YN, Wang
N, Zhou RM and Kang S: Association of polymorphisms −1154G/A and
−2578C/A in the vascular endothelial growth factor gene with
decreased risk of endometriosis in Chinese women. Hum Reprod.
24:2660–2666. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Brogan IJ, Khan N, Isaac K, Hutchinson JA,
Pravica V and Hutchinson IV: Novel polymorphisms in the promoter
and 5′ UTR regions of the human vascular endothelial growth factor
gene. Hum Immunol. 60:1245–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Watson CJ, Webb NJ, Bottomley MJ and
Brenchley PE: Identification of polymorphisms within the vascular
endothelial growth factor (VEGF) gene: correlation with variation
in VEGF protein production. Cytokine. 12:1232–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Akiri G, Nahari D, Finkelstein Y, Le SY,
Elroy-Stein O and Levi BZ: Regulation of vascular endothelial
growth factor (VEGF) expression is mediated by internal initiation
of translation and alternative initiation of transcription.
Oncogene. 17:227–236. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Stevens A, Soden J, Brenchley PE, Ralph S
and Ray DW: Haplotype analysis of the polymorphic human vascular
endothelial growth factor gene promoter. Cancer Res. 63:812–816.
2003.PubMed/NCBI
|
|
56
|
Renner W, Kotschan S, Hoffmann C,
Obermayer-Pietsch B and Pilger E: A common 936 C/T mutation in the
gene for vascular endothelial growth factor is associated with
vascular endothelial growth factor plasma levels. J Vasc Res.
37:443–448. 2000. View Article : Google Scholar : PubMed/NCBI
|
